These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

820 related items for PubMed ID: 33987769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B, Muschitz Ch, Gruber R, Brandtner Ch, Svejda Ch, Gasser RW, Santler G, Dimai HP.
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [Abstract] [Full Text] [Related]

  • 11. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
    Al-Omari FA, Kuroshima S, Sawase T.
    J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
    [Abstract] [Full Text] [Related]

  • 12. A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.
    Bracchi P, Zecca E, Brunelli C, Miceli R, Tinè G, Maniezzo M, Lo Dico S, Caputo M, Shkodra M, Caraceni AT.
    Cancer Med; 2023 Sep; 12(17):18317-18326. PubMed ID: 37559413
    [Abstract] [Full Text] [Related]

  • 13. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
    Tröltzsch M, Tröltzsch M, Pautke C, Otto S.
    HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
    [Abstract] [Full Text] [Related]

  • 14. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P, Engelhardt M, Schmelzeisen R, Voss P.
    Dtsch Arztebl Int; 2017 Feb 03; 114(5):63-69. PubMed ID: 28241916
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB, O'Ryan F.
    Oral Maxillofac Surg Clin North Am; 2015 Nov 03; 27(4):517-25. PubMed ID: 26515735
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Otto S, Aljohani S, Fliefel R, Ecke S, Ristow O, Burian E, Troeltzsch M, Pautke C, Ehrenfeld M.
    Medicina (Kaunas); 2021 May 09; 57(5):. PubMed ID: 34065104
    [Abstract] [Full Text] [Related]

  • 19. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M.
    Cancer Treat Rev; 2018 Sep 09; 69():177-187. PubMed ID: 30055439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.